Q&A: private antitrust litigation procedure in Belgium
This Q&A answers key procedural questions for claimants bringing private antitrust claims in Belgium, including with regard to evidence, time frames, limitation periods and appeals.
Stay updated with breaking news from Belgian Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This Q&A answers key procedural questions for claimants bringing private antitrust claims in Belgium, including with regard to evidence, time frames, limitation periods and appeals.
Investegate announcements from Oxurion NV, Information on the Total Number of Voting Rights (Denominator) following Conversion of Negma Convertible Bonds and Partial Reimbursement of Kreos/Pontifax Convertible Bonds
Negma Group has converted 180 convertible bonds resulting in a EUR 450,000 capital increase and Kreos/Pontifax convertible bonds have been reimbursed in an amount of EUR 3 million Leuven, BELGIUM
A look at some of the key regulatory issues and concerns surrounding bank loan facilities in Belgium, including capital, liquidity and disclosure requirements, among other things.
Investegate announcements from Acacia Pharma Group plc, Scheme of arrangement becoming effective